AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34701521 — intervention group
Group type: COMPARATOR
Intervention: MRI surveillance alone
Number of subjects: 0
Study 34701521 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippocampal-avoidance PCI (HA-PCI)
Number of subjects: 0
Study 34701521 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-IMRT with memantine for salvage treatment in MRI surveillance group
Number of subjects: 0
Study 34357539 — intervention group
Group type: EXPERIMENTAL
Intervention: Bot/VPN Check
Number of subjects: 1100
Study 34357539 — intervention group
Group type: EXPERIMENTAL
Intervention: Truthfulness/Attention Check
Number of subjects: 1100
Study 34357539 — intervention group
Group type: EXPERIMENTAL
Intervention: Stringent Arm - All Checks
Number of subjects: 1100
Study 34357539 — intervention group
Group type: COMPARATOR
Intervention: Control Arm
Number of subjects: 1100
Study 34189633 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle exoskeleton providing adaptive plantar-flexor assistance
Number of subjects: 7
Study 34189633 — intervention group
Group type: COMPARATOR
Intervention: Normal walking condition (without exoskeleton)
Number of subjects: 7
Study 32348168 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional anaesthesia (CA)
Number of subjects: 105
Study 32348168 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrational anaesthesia (VBA)
Number of subjects: 105
Study 32348168 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-controlled local anaesthesia delivery (CCLAD)
Number of subjects: 105
Study 36472933 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 3760
Study 36472933 — intervention group
Group type: COMPARATOR
Intervention: Diabetes support and education (Control)
Number of subjects: 3760
Study 33663100 — intervention group
Group type: EXPERIMENTAL
Intervention: Edaravone treatment on top of conventional treatment
Number of subjects: 60
Study 33663100 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 60
Study 34918875 — intervention group
Group type: EXPERIMENTAL
Intervention: Metopimazine (MPZ) 60 mg
Number of subjects: 0
Study 34779303 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone genetic counseling
Number of subjects: 669
Study 34779303 — intervention group
Group type: COMPARATOR
Intervention: Usual care genetic counseling
Number of subjects: 669
Study 32735218 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention (smartphone-assisted program using Samsung Health and WhatsApp)
Number of subjects: 33
Study 32735218 — intervention group
Group type: COMPARATOR
Intervention: Conventional behavior change intervention only
Number of subjects: 33
Study 33415653 — intervention group
Group type: EXPERIMENTAL
Intervention: PIFU (ePRO-based individual follow-up)
Number of subjects: 124
Study 33415653 — intervention group
Group type: COMPARATOR
Intervention: SFU (standard follow-up care)
Number of subjects: 124
Study 33415653 — intervention group
Group type: EXPERIMENTAL
Intervention: PIFU and SFU
Number of subjects: 124
Study 33430797 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning model for diagnosing dystrophinopathies on thigh muscle MRI images
Number of subjects: 432
Study 33430797 — intervention group
Group type: COMPARATOR
Intervention: Skilled radiologists
Number of subjects: 432
Study 32948695 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed digital twin test
Number of subjects: 0
Study 32948695 — intervention group
Group type: COMPARATOR
Intervention: Transmission disequilibrium test
Number of subjects: 0
Study 35145122 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV-VG group
Number of subjects: 63
Study 35145122 — intervention group
Group type: COMPARATOR
Intervention: VCV group
Number of subjects: 63
Study 35145122 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 63
Study 33091723 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual score of 4 (acceptance threshold)
Number of subjects: 4322
Study 34623746 — intervention group
Group type: EXPERIMENTAL
Intervention: Seton removal + surgical closure (closure group)
Number of subjects: 64
Study 34623746 — intervention group
Group type: COMPARATOR
Intervention: Seton removal alone (control group)
Number of subjects: 64
Study 34470300 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported occupational noise exposure
Number of subjects: 6318
Study 32981872 — intervention group
Group type: EXPERIMENTAL
Intervention: Panoramic reconstruction (PR) images
Number of subjects: 10
Study 32981872 — intervention group
Group type: COMPARATOR
Intervention: Multiplanar reconstruction (MPR) images
Number of subjects: 10
Study 32981872 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision making by oral and maxillofacial surgeons (OMFSs)
Number of subjects: 10
Study 34863618 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 vaccination intent among residents
Number of subjects: 969
Study 34863618 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 vaccination intent among staff
Number of subjects: 969
Study 34863618 — intervention group
Group type: COMPARATOR
Intervention: Factors associated with vaccine deliberation and reluctance
Number of subjects: 969
Study 34863618 — intervention group
Group type: COMPARATOR
Intervention: Trend in vaccine acceptance
Number of subjects: 969
Study 35227528 — intervention group
Group type: EXPERIMENTAL
Intervention: Flowable short fiber-reinforced composites (SFRC)
Number of subjects: 250
Study 35227528 — intervention group
Group type: EXPERIMENTAL
Intervention: Packable short fiber-reinforced composites (SFRC)
Number of subjects: 250
Study 35227528 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber-reinforced glass-ionomer cement (GIC) with adhesive treatment
Number of subjects: 250
Study 35227528 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber-reinforced glass-ionomer cement (GIC) without adhesive treatment
Number of subjects: 250
Study 35227528 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional glass-ionomer cement (GIC) with adhesive treatment
Number of subjects: 250
Study 35227528 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-modified glass-ionomer cement (GIC) with adhesive treatment
Number of subjects: 250
Study 35227528 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional glass-ionomer cement (GIC) without adhesive treatment
Number of subjects: 250
Study 35227528 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-modified glass-ionomer cement (GIC) without adhesive treatment
Number of subjects: 250
Study 35227528 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-cure composite resin
Number of subjects: 250
Study 35227528 — intervention group
Group type: COMPARATOR
Intervention: Conventional composite resin (control)
Number of subjects: 250
Study 32151432 — intervention group
Group type: EXPERIMENTAL
Intervention: Anemia
Number of subjects: 1748
Study 35753316 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional doses of RTS,S/AS01E (Fx012-14)
Number of subjects: 1609
Study 35753316 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard regimen of RTS,S/AS01E (R012-14 and R012-20)
Number of subjects: 1609
Study 35753316 — intervention group
Group type: COMPARATOR
Intervention: Rabies vaccine (control group)
Number of subjects: 1609
Study 35753316 — intervention group
Group type: EXPERIMENTAL
Intervention: Full doses of RTS,S/AS01E (R012-20)
Number of subjects: 1609
Study 35753316 — intervention group
Group type: EXPERIMENTAL
Intervention: Full doses of RTS,S/AS01E (R012-14)
Number of subjects: 1609
Study 35753316 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional doses of RTS,S/AS01E (Fx017-20)
Number of subjects: 1609
Study 33131033 — intervention group
Group type: EXPERIMENTAL
Intervention: O3-autohemotherapy plus BAT
Number of subjects: 60
Study 33131033 — intervention group
Group type: COMPARATOR
Intervention: BAT only (Control)
Number of subjects: 60
Study 32052032 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 (0.8 pmol/kg/min)
Number of subjects: 18
Study 32052032 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (rate-matched infusion)
Number of subjects: 18
Study 36159932 — intervention group
Group type: EXPERIMENTAL
Intervention: Jin's three-needle therapy (JTNT)
Number of subjects: 114
Study 36159932 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 114
Study 36159932 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (no treatment)
Number of subjects: 114
Study 32079855 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 310
Study 32079855 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 310
Study 32079855 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 310
Study 32079855 — intervention group
Group type: EXPERIMENTAL
Intervention: Family history of CHD
Number of subjects: 310
Study 32079855 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 310
Study 32079855 — intervention group
Group type: EXPERIMENTAL
Intervention: GG genotype at rs10757278
Number of subjects: 310
Study 35788240 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Functional Therapy (CFT) intervention, 5 to 7 sessions based on clinical progression.
Number of subjects: 152
Study 35788240 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention, 6 sessions of photobiomodulation using a detuned device and neutral conversation.
Number of subjects: 152
Study 33722669 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate/protein breakfast
Number of subjects: 0
Study 33722669 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition-manipulation inducing plasma tryptophan fluctuation
Number of subjects: 0
Study 33722669 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI activation in the parietal lobule during risk-processing
Number of subjects: 0
Study 32829703 — intervention group
Group type: EXPERIMENTAL
Intervention: Mumps-specific IgG antibody testing using Enzygnost anti-parotitis IgG enzyme immunoassay
Number of subjects: 2729
Study 32829703 — intervention group
Group type: COMPARATOR
Intervention: Comparison with previous national serosurveys (2007-2008 and 1997-1998)
Number of subjects: 2729
Study 32829703 — intervention group
Group type: EXPERIMENTAL
Intervention: Age group analysis
Number of subjects: 2729
Study 35715625 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal insulin
Number of subjects: 60
Study 35715625 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34783839 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan
Number of subjects: 2572
Study 34783839 — intervention group
Group type: COMPARATOR
Intervention: Background medication-based individualized comparator (enalapril, valsartan, or placebo)
Number of subjects: 2572
Study 34783839 — intervention group
Group type: COMPARATOR
Intervention: Background medication-based individualized comparator
Number of subjects: 2572
Study 32865762 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 0
Study 32865762 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 0
Study 33395500 — intervention group
Group type: EXPERIMENTAL
Intervention: Health coaching intervention
Number of subjects: 108
Study 33395500 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 108
Study 35667389 — intervention group
Group type: EXPERIMENTAL
Intervention: RFA followed by SEMS insertion (n=42)
Number of subjects: 86
Study 35667389 — intervention group
Group type: COMPARATOR
Intervention: Self‐expandable metal stent only (SEMS‐only, n=44)
Number of subjects: 86
Study 33044196 — intervention group
Group type: EXPERIMENTAL
Intervention: Active antidepressants (fluoxetine, duloxetine, paroxetine, sertraline)
Number of subjects: 4717
Study 33044196 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4717
Study 35354342 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting balloon (DEB)
Number of subjects: 42
Study 35354342 — intervention group
Group type: COMPARATOR
Intervention: Plain old balloon angioplasty (POBA)
Number of subjects: 42
Study 34863138 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved biomass cookstoves
Number of subjects: 200
Study 34863138 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional stoves)
Number of subjects: 200
Study 35638415 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 153
Study 35638415 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation Training (RT)
Number of subjects: 153
Study 35638415 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 153
Study 33938432 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination serum containing galactomyces ferment filtrate (GFF), dexpanthenol, and Centella asiatica, administered as three drops twice daily for 8 weeks.
Number of subjects: 51
Study 33938432 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 51
Study 33938432 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination serum containing GFF, dexpanthenol, and C. asiatica
Number of subjects: 51
Study 32878759 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined physical and psychological intervention (BOOST programme)
Number of subjects: 0
Study 35325703 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L
Number of subjects: 715
Study 35325703 — intervention group
Group type: EXPERIMENTAL
Intervention: ICECAP-O
Number of subjects: 715
Study 35325703 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L and ICECAP-O
Number of subjects: 715
Study 33878196 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae block
Number of subjects: 60
Study 33878196 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 60
Study 36115638 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion Regulation Therapy for Caregivers (ERT-C)
Number of subjects: 200
Study 36115638 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy for Caregivers (CBT-C)
Number of subjects: 200
Study 33931185 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 sessions of rTMS
Number of subjects: 90
Study 33931185 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 sessions of rTMS
Number of subjects: 90
Study 33931185 — intervention group
Group type: EXPERIMENTAL
Intervention: Both rTMS protocols
Number of subjects: 90
Study 34614146 — intervention group
Group type: EXPERIMENTAL
Intervention: POD24 (progression of disease within 24 months)
Number of subjects: 5225
Study 34614146 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical factors predicting POD24
Number of subjects: 5225
Study 34535197 — intervention group
Group type: EXPERIMENTAL
Intervention: TPX-100 (200 mg)
Number of subjects: 104
Study 34535197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 32571432 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic promotion of the StopBlues program by local authorities
Number of subjects: 34
Study 32571432 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified promotion of the StopBlues program in a general practitioner's waiting room
Number of subjects: 34
Study 32571432 — intervention group
Group type: COMPARATOR
Intervention: Control group with no initial promotion, followed by sustained promotion after 12 months
Number of subjects: 34
Study 32571432 — intervention group
Group type: EXPERIMENTAL
Intervention: StopBlues program usage
Number of subjects: 34
Study 32571432 — intervention group
Group type: EXPERIMENTAL
Intervention: Help-seeking behaviors
Number of subjects: 34
Study 32571432 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological distress
Number of subjects: 34
Study 32571432 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness and budgetary impact
Number of subjects: 34
Study 36001764 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased daytime physical activity
Number of subjects: 0
Study 36001764 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher behavioral and psychological symptoms of dementia (BPSD)
Number of subjects: 0
Study 33268017 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT oil dietary supplementation
Number of subjects: 29
Study 33268017 — intervention group
Group type: COMPARATOR
Intervention: Control oil dietary supplementation
Number of subjects: 29
Study 34414904 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol 500 mg a day with meloxicam 15 mg a day for 90 days
Number of subjects: 110
Study 34414904 — intervention group
Group type: COMPARATOR
Intervention: Placebo with meloxicam 15 mg a day for 90 days
Number of subjects: 110
Study 36312793 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention group
Number of subjects: 32
Study 36312793 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 32245343 — intervention group
Group type: EXPERIMENTAL
Intervention: Median Urinary Iodine Concentration (MUI) measured in 1997, 1999, 2011, 2014, and 2017 with values of 228 µg/L, 214 µg/L, 1826 µg/L, 171 µg/L, and 183 µg/L respectively.
Number of subjects: 1200
Study 32245343 — intervention group
Group type: EXPERIMENTAL
Intervention: Median Thyroid Volume (MTvol) measured in 1997, 1999, 2011, 2014, and 2017 with values of 2.9 mL, 1.2 mL, 2.4 mL, 1.0 mL, and 1.8 mL, and 2.8 mL respectively.
Number of subjects: 1200
Study 35872963 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention
Number of subjects: 126
Study 35872963 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 126
Study 33618027 — intervention group
Group type: EXPERIMENTAL
Intervention: All colonoscopies (irrespective of indication)
Number of subjects: 2628
Study 33618027 — intervention group
Group type: COMPARATOR
Intervention: Screening exams
Number of subjects: 2628
Study 33618027 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveillance exams
Number of subjects: 2628
Study 33618027 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic exams
Number of subjects: 2628
Study 32544269 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser group (LG, InGaAlP, 660 nm, 86.7 mW, 2 J/cm2)
Number of subjects: 54
Study 32544269 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG, simulated procedure without light emission)
Number of subjects: 54
Study 35751161 — intervention group
Group type: EXPERIMENTAL
Intervention: Efavirenz (EFV) at a daily dose of 600 mg orally in combination with other antiretrovirals (ARVs)
Number of subjects: 96
Study 35751161 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2B6 516G>T genotype (wild-type GG, heterozygote GT, polymorphic homozygote TT)
Number of subjects: 96
Study 34567245 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary cytoreduction and HIPEC (Cisplatin 75 mg/m2 43°C over 60 minutes)
Number of subjects: 15
Study 33189262 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed buffer powder (MBP)
Number of subjects: 80
Study 33189262 — intervention group
Group type: COMPARATOR
Intervention: Basic bicarbonate electrolyte powder (BBP)
Number of subjects: 80
Study 33189262 — intervention group
Group type: COMPARATOR
Intervention: Liquid electrolyte (HAL)
Number of subjects: 80
Study 33189262 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments (BBP, MBP, HAL)
Number of subjects: 80
Study 33942292 — intervention group
Group type: EXPERIMENTAL
Intervention: R-CHOP plus ibrutinib
Number of subjects: 746
Study 33942292 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 746
Study 32947569 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-load resistance training (LLRT; loads <50% of 1 repetition maximum [1RM])
Number of subjects: 29
Study 32947569 — intervention group
Group type: COMPARATOR
Intervention: Higher-load resistance training (HLRT; loads >70% of 1 repetition maximum [1RM])
Number of subjects: 29
Study 33423544 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 13
Study 33423544 — intervention group
Group type: COMPARATOR
Intervention: SHAM
Number of subjects: 13
Study 36090567 — intervention group
Group type: EXPERIMENTAL
Intervention: 80:40 group (80 mg/kg/day ARA and 40 mg/kg/day DHA)
Number of subjects: 18
Study 36090567 — intervention group
Group type: EXPERIMENTAL
Intervention: 120:60 group (120 mg/kg/day ARA and 60 mg/kg/day DHA)
Number of subjects: 18
Study 36090567 — intervention group
Group type: EXPERIMENTAL
Intervention: 120:60 group
Number of subjects: 18
Study 36090567 — intervention group
Group type: COMPARATOR
Intervention: 80:40 group
Number of subjects: 18
Study 35930838 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbially diverse sand
Number of subjects: 26
Study 35930838 — intervention group
Group type: COMPARATOR
Intervention: Placebo sand
Number of subjects: 26
Study 34609956 — intervention group
Group type: EXPERIMENTAL
Intervention: Asynchronous Video Observed Treatment (aVOT)
Number of subjects: 647
Study 34609956 — intervention group
Group type: COMPARATOR
Intervention: Directly Observed Treatment (DOT)
Number of subjects: 647
Study 32828623 — intervention group
Group type: EXPERIMENTAL
Intervention: Right ventricular apical (RVA) pacing
Number of subjects: 284
Study 32828623 — intervention group
Group type: COMPARATOR
Intervention: Non-RVA pacing
Number of subjects: 284
Study 32828623 — intervention group
Group type: EXPERIMENTAL
Intervention: RVA pacing
Number of subjects: 284
Study 36385690 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate containing beetroot juice (400 mg daily)
Number of subjects: 49
Study 36385690 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg daily)
Number of subjects: 49
Study 33305862 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency (10 Hz) rTMS
Number of subjects: 388
Study 33305862 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent theta-burst stimulation (iTBS)
Number of subjects: 388
Study 33305862 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 388
Study 624995555 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal CPAP (8-10 cm H2O)
Number of subjects: 55
Study 624995555 — intervention group
Group type: COMPARATOR
Intervention: Sham CPAP (<2 cm H2O)
Number of subjects: 55
Study 624995555 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 55
Study 33974126 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 bouts of 4 s maximal cycling sprints with 15 s recovery
Number of subjects: 16
Study 33974126 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 bouts of 4 s maximal cycling sprints with 30 s recovery
Number of subjects: 16